Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma

Non-small cell lung cancer is still diagnosed at late stage due to the lack of early symptoms and methods of diagnostic prevention. In the past ten years several targeted therapies have been introduced or explored. Tyrosine kinase inhibitors and immunotherapy are currently considered the most effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respir Med Case Rep
Hauptverfasser: Zarogoulidis, Paul, Huang, Haidong, Tsiouda, Theodora, Sardeli, Chrysa, Trakada, Georgia, Veletza, Lemonia, Kallianos, Anastasios, Kosmidis, Christoforos, Rapti, Aggeliki, Papaemmanouil, Liana, Hatzibougias, Dimitrios, Drougas, Dimitrios, Bai, Chong, Hohenforst-Schmidt, Wolfgang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2017
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5671388/
https://ncbi.nlm.nih.gov/pubmed/29124007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.10.006
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge